Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 11.28%44.54B | 2.87%171.48B | 1.31%129.83B | 1.56%80.76B | -0.11%40.02B | 18.14%166.7B | 21.50%128.15B | 33.39%79.52B | 59.83%40.07B | 166.74%141.1B |
| Operating income | 11.28%44.54B | 2.87%171.48B | 1.31%129.83B | 1.56%80.76B | -0.11%40.02B | 18.14%166.7B | 21.50%128.15B | 33.39%79.52B | 59.83%40.07B | 166.74%141.1B |
| Operating expenses | -3.07%-41.03B | -0.76%-120.66B | -2.80%-39.81B | -22.99%-119.75B | -47.15%-38.73B | |||||
| Gross profit | 1,567.60%3.5B | 9.12%9.17B | -84.29%210.05M | 3.52%8.4B | 206.81%1.34B | |||||
| Selling expenses | 1.28%-1.72B | -4.74%-4.92B | -5.29%-5.26B | -5.91%-2.41B | -0.02%-1.74B | -37.16%-4.7B | -24.92%-4.99B | -47.56%-2.28B | -55.41%-1.74B | -108.76%-3.42B |
| Administrative expenses | 0.59%-1.32B | -2.68%-1.92B | -1.34%-3.97B | -2.22%-797.63M | -2.99%-1.33B | -11.22%-1.87B | -5.15%-3.92B | -10.50%-780.31M | -16.15%-1.29B | -35.71%-1.68B |
| Research and development expenses | -12.64%-96.02M | ---- | -6.49%-312.48M | ---- | 0.07%-85.25M | ---- | -37.23%-293.45M | ---- | -22.43%-85.31M | ---- |
| Profit from asset sales | -135.64%-3.18M | ---- | -97.56%23.38M | ---- | 431.15%8.91M | ---- | 38.94%958.22M | ---- | -110.61%-2.69M | ---- |
| Employee expense | ---- | -8.11%-37.05B | ---- | -5.28%-17.85B | ---- | -16.96%-34.27B | ---- | -24.71%-16.95B | ---- | -15.64%-29.3B |
| Depreciation and amortization | ---- | -5.55%-30.72B | ---- | -5.79%-14.84B | ---- | -7.35%-29.1B | ---- | -10.39%-14.03B | ---- | -27.68%-27.11B |
| Revaluation surplus | -2,250.00%-43K | ---- | 1,495.45%1.4M | ---- | -94.12%2K | ---- | 112.38%88K | ---- | 112.55%34K | ---- |
| -Changes in the fair value of other assets | -2,250.00%-43K | ---- | 1,495.45%1.4M | ---- | -94.12%2K | ---- | 112.38%88K | ---- | 112.55%34K | ---- |
| Impairment and provision | 223.30%5.27M | -319.44%-560.93M | -1,005.43%-95.13M | -508.63%-87.24M | 57.29%-4.27M | 36.82%-133.73M | 93.05%-8.61M | 86.04%-14.33M | -126.10%-10M | -406.39%-211.67M |
| -Goodwill impairment | ---- | ---483.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 223.30%5.27M | 42.14%-77.38M | -1,005.43%-95.13M | -508.63%-87.24M | 57.29%-4.27M | 36.82%-133.73M | 93.05%-8.61M | 86.04%-14.33M | -126.10%-10M | -406.39%-211.67M |
| Special items of operating profit | 28.88%2.42B | -2.44%-96.71B | 6.46%5.75B | 0.17%-46.47B | 16.46%1.88B | -23.44%-94.41B | -0.94%5.4B | -46.11%-46.55B | 18.20%1.61B | -96.88%-76.48B |
| Operating profit | 330.94%2.68B | -117.55%-389.2M | -5.49%5B | -56.79%-1.7B | -379.96%-1.16B | -23.23%2.22B | -10.91%5.29B | -20.46%-1.08B | 89.18%-241.86M | 108.15%2.89B |
| Financing income | -33.22%87.83M | 9.12%568.91M | 13.74%438.62M | 16.36%285.79M | -1.57%131.53M | -13.83%521.36M | -19.84%385.63M | -15.70%245.62M | 21.50%133.63M | 164.52%605M |
| Financing cost | 17.57%-1.21B | 13.22%-5.55B | 12.33%-4.25B | 11.47%-2.89B | 12.32%-1.47B | 7.84%-6.4B | 8.97%-4.85B | 7.82%-3.27B | 0.34%-1.68B | -7.27%-6.94B |
| Share of profits of associates | ---- | 20.11%3.14B | ---- | 12.48%1.22B | ---- | 2.20%2.61B | ---- | -14.28%1.08B | ---- | 635.05%2.55B |
| Share of profit from joint venture company | ---- | 38.64%289.93M | ---- | 28.29%117.21M | ---- | -25.20%209.12M | ---- | 2.86%91.36M | ---- | -25.82%279.57M |
| Special items of earning before tax | 113.01%128.87M | 143.13%327.56M | -47.46%131.06M | 148.92%176.31M | 195.04%60.5M | 26.63%-759.52M | -81.81%249.45M | 76.97%-360.42M | 63.87%20.51M | 74.68%-1.04B |
| Earning before tax | 177.34%1.9B | -1.33%-1.62B | 25.60%1.36B | 15.16%-2.79B | -27.36%-2.45B | 3.09%-1.6B | 14.67%1.08B | 24.63%-3.29B | 41.32%-1.93B | 96.40%-1.65B |
| Tax | ---- | -127.09%-1.92B | ---- | 130.81%77.8M | ---- | -1,056.13%-846.47M | ---- | -179.86%-252.54M | ---- | -87.41%88.53M |
| After-tax profit from continuing operations | 170.74%1.79B | -44.86%-3.54B | 76.41%1.36B | 23.41%-2.71B | -26.64%-2.54B | -56.63%-2.45B | -35.18%769.27M | 12.50%-3.54B | 38.85%-2B | 96.54%-1.56B |
| Earning after tax | 170.74%1.79B | -44.86%-3.54B | 76.41%1.36B | 23.41%-2.71B | -26.64%-2.54B | -56.63%-2.45B | -35.18%769.27M | 12.50%-3.54B | 38.85%-2B | 96.54%-1.56B |
| Minority profit | 116.13%79.24M | 20.71%-1.75B | 13.46%-512.74M | -19.17%-905.29M | -50.03%-491.25M | -323.23%-2.21B | -249.84%-592.48M | -27.22%-759.66M | 5.70%-327.44M | 92.03%-522.84M |
| Profit attributable to shareholders | 183.86%1.71B | -668.82%-1.79B | 37.31%1.87B | 35.05%-1.8B | -22.07%-2.04B | 77.60%-232.56M | 72.06%1.36B | 19.38%-2.78B | 42.78%-1.67B | 97.31%-1.04B |
| Basic earnings per share | 183.33%0.1 | -1,000.00%-0.11 | 22.22%0.11 | 38.89%-0.11 | -9.09%-0.12 | 85.16%-0.01 | 80.00%0.09 | 19.61%-0.18 | 42.11%-0.11 | 97.60%-0.0674 |
| Diluted earnings per share | 183.33%0.1 | -1,000.00%-0.11 | 22.22%0.11 | 38.89%-0.11 | -9.09%-0.12 | 85.16%-0.01 | 80.00%0.09 | 19.61%-0.18 | -0.11 | 97.60%-0.0674 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Accounting Firm | -- | -- | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.